Contributor content
Presentation
From evidence to practice: Mavacamten in obstructive Hypertrophic Cardiomyopathy - data from the multicenter TORCH-Plus-DZHK21 registry
Presentation
Comparison of transcoronary ablation of septal hypertrophy (TASH) and Mavacamten treatment in patients with obstructive hypertrophic cardiomyopathy: a single-center study
Presentation



